特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界の中枢神経系バイオマーカーの市場:規模、情勢、および予測(2019年~2025年)

Global Central Nervous System Biomarkers Market Size, Status and Forecast 2019-2025

発行 QYResearch 商品コード 916070
出版日 ページ情報 英文 97 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=107.13円で換算しております。
世界の中枢神経系バイオマーカーの市場:規模、情勢、および予測(2019年~2025年) Global Central Nervous System Biomarkers Market Size, Status and Forecast 2019-2025
出版日: 2019年11月11日 ページ情報: 英文 97 Pages
概要

当レポートは世界の中枢神経系バイオマーカー市場について調査しており、市場成長要因、動向や課題、用途・タイプ・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 レポートの概要

  • 調査範囲
  • 主要市場セグメント
  • 対象となる企業
  • 市場セグメント:タイプ別
    • 市場規模の成長率
    • 安全性バイオマーカー
    • 有効性バイオマーカー
    • 検証バイオマーカー
    • その他
  • 市場セグメント:用途別
    • 市場のシェア
    • 病院
    • 診療所
    • その他
  • 調査の目的
  • 考慮される年

第2章 世界の成長動向

  • 市場規模
  • 成長動向:地域別
    • 市場規模
    • 市場シェア
  • 産業の動向
    • 市場の主な動向
    • 市場成長要因
    • 市場の課題
    • ポーターのファイブフォース分析

第3章 市場シェア:主要企業別

  • 市場規模
    • 収益
    • 収益市場シェア
    • 市場集中率(CR5およびHHI)
  • 主要企業の本社・提供エリア
  • 製品/ソリューション/サービス
  • 市場参入日
  • 合併・買収、拡張計画

第4章 市場分析:タイプ・用途別

  • タイプ別
  • 用途別

第5章 北米

  • 市場規模
  • 主要企業
  • タイプ別
  • 用途別

第6章 欧州

第7章 中国

第8章 日本

第9章 東南アジア

第10章 インド

第11章 中南米

第12章 企業プロファイル

  • Merck
  • 武田薬品工業株式会社
  • Thermo Fisher Scientific
  • Avacta Group
  • Diagenic Asa
  • Banyan Biomarkers
  • Eli Lilly
  • Pfizer
  • Alseres Pharmaceuticals
  • Acumen pharmaceuticals
  • EKF Diagnostics
  • Abiant
  • Myriad RBM
  • Aposense

第13章 市場予測

  • 製品別
  • 用途別
  • 地域別
  • 北米
  • 欧州
  • 中国
  • 日本
  • 東南アジア
  • インド
  • 中南米

第14章 アナリストの見解・結論

第15章 付録

  • 調査方法
    • 調査方法・調査アプローチ
    • 情報源
  • 免責事項
  • 著者の詳細
図表

List of Tables and Figures

  • Table Central Nervous System Biomarkers Key Market Segments
  • Table Key Players Central Nervous System Biomarkers Covered
  • Table Global Central Nervous System Biomarkers Market Size Growth Rate by Type 2018-2025 (Million US$)
  • Figuer Safety Biomarker Figures
  • Table Key Players of Safety Biomarker
  • Figuer Efficacy Biomarker Figures
  • Table Key Players of Efficacy Biomarker
  • Figuer Validation Biomarker Figures
  • Table Key Players of Validation Biomarker
  • Figuer Other Figures
  • Table Key Players of Other
  • Table Global Central Nervous System Biomarkers Market Size Growth by Application 2019-2025 (Million US$)
  • Figure Global Central Nervous System Biomarkers Market Share by Application in 2018 & 2025
  • Figure Hospitals Case Studies
  • Figure Clinics Case Studies
  • Figure Others Case Studies
  • Figure Central Nervous System Biomarkers Report Years Considered
  • Figure Global Central Nervous System Biomarkers Market Size and Growth Rate 2014-2025 (Million US$)
  • Table Global Central Nervous System Biomarkers Market Size by Regions 2019-2025 (Million US$)
  • Table Global Central Nervous System Biomarkers Market Size by Regions 2019-2025 (Million US$)
  • Table Global Central Nervous System Biomarkers Market Share by Regions 2014-2019
  • Figure Global Central Nervous System Biomarkers Market Share by Regions 2014-2019
  • Figure Global Central Nervous System Biomarkers Market Share by Regions in 2018
  • Table Market Top Trends
  • Table Key Drivers: Impact Analysis (2019-2025)
  • Table Key Challenges
  • Figure PORTER'S FIVE FORCES ANALYSIS
  • Table Global Central Nervous System Biomarkers Revenue by by Players (2014-2019) (Million US$)
  • Table Global Central Nervous System Biomarkers Market Share by by Players (2014-2019)
  • Figure Global Central Nervous System Biomarkers Market Share by by Players in 2018
  • Table Global Central Nervous System Biomarkers by Players Market Concentration Ratio (CR5 and HHI)
  • Table Key Players Head office and Area Served
  • Table Key Players Central Nervous System Biomarkers Product/Solution/Service
  • Table Date of Enter into Central Nervous System Biomarkers Market
  • Table Mergers & Acquisitions, Expansion Plans
  • Table Global Central Nervous System Biomarkers Market Size by Type (2014-2019) (Million US$)
  • Table Global Central Nervous System Biomarkers Market Size Share by Type (2014-2019)
  • Figure Global Central Nervous System Biomarkers Market Size Market Share by Type (2014-2019)
  • Table Global Central Nervous System Biomarkers Market Size by Application (2014-2019) (Million US$)
  • Table Global Central Nervous System Biomarkers Market Size Share by Application (2014-2019)
  • Figure Global Central Nervous System Biomarkers Market Size Market Share by Application (2014-2019)
  • Figure Global Central Nervous System Biomarkers Revenue Market Share by Application in 2018
  • Figure North America Central Nervous System Biomarkers Market Size 2014-2019 (Million US$)
  • Table North America Key Players Central Nervous System Biomarkers Revenue (2018-2019) (Million US$)
  • Table North America Key Players Central Nervous System Biomarkers Market Share (2018-2019)
  • Table North America Central Nervous System Biomarkers Market Size by Type 2014-2019 (Million US$)
  • Table North America Central Nervous System Biomarkers Market Share by Type 2014-2019
  • Table North America Central Nervous System Biomarkers Market Size by Application 2014-2019 (Million US$)
  • Table North America Central Nervous System Biomarkers Market Share by Application 2014-2019
  • Figure Europe Central Nervous System Biomarkers Market Size 2014-2019 (Million US$)
  • Table Europe Key Players Central Nervous System Biomarkers Revenue (2018-2019) (Million US$)
  • Table Europe Key Players Central Nervous System Biomarkers Market Share (2018-2019)
  • Table Europe Central Nervous System Biomarkers Market Size by Type 2014-2019 (Million US$)
  • Table Europe Central Nervous System Biomarkers Market Share by Type 2014-2019
  • Table Europe Central Nervous System Biomarkers Market Size by Application 2014-2019 (Million US$)
  • Table Europe Central Nervous System Biomarkers Market Share by Application 2014-2019
  • Figure China Central Nervous System Biomarkers Market Size 2014-2019 (Million US$)
  • Table China Key Players Central Nervous System Biomarkers Revenue (2018-2019) (Million US$)
  • Table China Key Players Central Nervous System Biomarkers Market Share (2018-2019)
  • Table China Central Nervous System Biomarkers Market Size by Type 2014-2019 (Million US$)
  • Table China Central Nervous System Biomarkers Market Share by Type 2014-2019
  • Table China Central Nervous System Biomarkers Market Size by Application 2014-2019 (Million US$)
  • Table China Central Nervous System Biomarkers Market Share by Application 2014-2019
  • Figure Japan Central Nervous System Biomarkers Market Size 2014-2019 (Million US$)
  • Table Japan Key Players Central Nervous System Biomarkers Revenue (2018-2019) (Million US$)
  • Table Japan Key Players Central Nervous System Biomarkers Market Share (2018-2019)
  • Table Japan Central Nervous System Biomarkers Market Size by Type 2014-2019 (Million US$)
  • Table Japan Central Nervous System Biomarkers Market Share by Type 2014-2019
  • Table Japan Central Nervous System Biomarkers Market Size by Application 2014-2019 (Million US$)
  • Table Japan Central Nervous System Biomarkers Market Share by Application 2014-2019
  • Figure Southeast Asia Central Nervous System Biomarkers Market Size 2014-2019 (Million US$)
  • Table Southeast Asia Key Players Central Nervous System Biomarkers Revenue (2018-2019) (Million US$)
  • Table Southeast Asia Key Players Central Nervous System Biomarkers Market Share (2018-2019)
  • Table Southeast Asia Central Nervous System Biomarkers Market Size by Type 2014-2019 (Million US$)
  • Table Southeast Asia Central Nervous System Biomarkers Market Share by Type 2014-2019
  • Table Southeast Asia Central Nervous System Biomarkers Market Size by Application 2014-2019 (Million US$)
  • Table Southeast Asia Central Nervous System Biomarkers Market Share by Application 2014-2019
  • Figure India Central Nervous System Biomarkers Market Size 2014-2019 (Million US$)
  • Table India Key Players Central Nervous System Biomarkers Revenue (2018-2019) (Million US$)
  • Table India Key Players Central Nervous System Biomarkers Market Share (2018-2019)
  • Table India Central Nervous System Biomarkers Market Size by Type 2014-2019 (Million US$)
  • Table India Central Nervous System Biomarkers Market Share by Type 2014-2019
  • Table India Central Nervous System Biomarkers Market Size by Application 2014-2019 (Million US$)
  • Table India Central Nervous System Biomarkers Market Share by Application 2014-2019
  • Figure Central & South America Central Nervous System Biomarkers Market Size 2014-2019 (Million US$)
  • Table Central & South America Key Players Central Nervous System Biomarkers Revenue (2018-2019) (Million US$)
  • Table Central & South America Key Players Central Nervous System Biomarkers Market Share (2018-2019)
  • Table Central & South America Central Nervous System Biomarkers Market Size by Type 2014-2019 (Million US$)
  • Table Central & South America Central Nervous System Biomarkers Market Share by Type 2014-2019
  • Table Central & South America Central Nervous System Biomarkers Market Size by Application 2014-2019 (Million US$)
  • Table Central & South America Central Nervous System Biomarkers Market Share by Application 2014-2019
  • Table Merck Company Details
  • Table Merck Revenue in Central Nervous System Biomarkers Business 2014-2019 (Million US$)
  • Figure Merck Revenue Growth Rate in Central Nervous System Biomarkers Business (2014-2019)
  • Table Merck Recent Development
  • Table Takeda Pharmaceutical Company Details
  • Table Takeda Pharmaceutical Revenue in Central Nervous System Biomarkers Business 2014-2019 (Million US$)
  • Figure Takeda Pharmaceutical Revenue Growth Rate in Central Nervous System Biomarkers Business (2014-2019)
  • Table Takeda Pharmaceutical Recent Development
  • Table Thermo Fisher Scientific Company Details
  • Table Thermo Fisher Scientific Revenue in Central Nervous System Biomarkers Business 2014-2019 (Million US$)
  • Figure Thermo Fisher Scientific Revenue Growth Rate in Central Nervous System Biomarkers Business (2014-2019)
  • Table Thermo Fisher Scientific Recent Development
  • Table Avacta Group Company Details
  • Table Avacta Group Revenue in Central Nervous System Biomarkers Business 2014-2019 (Million US$)
  • Figure Avacta Group Revenue Growth Rate in Central Nervous System Biomarkers Business (2014-2019)
  • Table Avacta Group Recent Development
  • Table Diagenic Asa Company Details
  • Table Diagenic Asa Revenue in Central Nervous System Biomarkers Business 2014-2019 (Million US$)
  • Figure Diagenic Asa Revenue Growth Rate in Central Nervous System Biomarkers Business (2014-2019)
  • Table Diagenic Asa Recent Development
  • Table Banyan Biomarkers Company Details
  • Table Banyan Biomarkers Revenue in Central Nervous System Biomarkers Business 2014-2019 (Million US$)
  • Figure Banyan Biomarkers Revenue Growth Rate in Central Nervous System Biomarkers Business (2014-2019)
  • Table Banyan Biomarkers Recent Development
  • Table Eli Lilly Company Details
  • Table Eli Lilly Revenue in Central Nervous System Biomarkers Business 2014-2019 (Million US$)
  • Figure Eli Lilly Revenue Growth Rate in Central Nervous System Biomarkers Business (2014-2019)
  • Table Eli Lilly Recent Development
  • Table Pfizer Company Details
  • Table Pfizer Revenue in Central Nervous System Biomarkers Business 2014-2019 (Million US$)
  • Figure Pfizer Revenue Growth Rate in Central Nervous System Biomarkers Business (2014-2019)
  • Table Pfizer Recent Development
  • Table Alseres Pharmaceuticals Company Details
  • Table Alseres Pharmaceuticals Revenue in Central Nervous System Biomarkers Business 2014-2019 (Million US$)
  • Figure Alseres Pharmaceuticals Revenue Growth Rate in Central Nervous System Biomarkers Business (2014-2019)
  • Table Alseres Pharmaceuticals Recent Development
  • Table Acumen pharmaceuticals Company Details
  • Table Acumen pharmaceuticals Revenue in Central Nervous System Biomarkers Business 2014-2019 (Million US$)
  • Figure Acumen pharmaceuticals Revenue Growth Rate in Central Nervous System Biomarkers Business (2014-2019)
  • Table Acumen pharmaceuticals Recent Development
  • Table EKF Diagnostics Company Details
  • Table Abiant Company Details
  • Table Myriad RBM Company Details
  • Table Aposense Company Details
  • Table Global Central Nervous System Biomarkers Market Size by Regions (Million US$) 2019-2025
  • Figure Global Central Nervous System Biomarkers Market Size Share by Regions (2019-2025)
  • Figure Global Central Nervous System Biomarkers Market Size Share by Regions in 2025
  • Figure North America Central Nervous System Biomarkers Market Size Forecast (2019-2025)(Million USD)
  • Figure Europe Central Nervous System Biomarkers Market Size Forecast (2019-2025)(Million USD)
  • Figure China Central Nervous System Biomarkers Market Size Forecast (2019-2025)(Million USD)
  • Figure Japan Central Nervous System Biomarkers Market Size Forecast (2019-2025)(Million USD)
  • Figure Southeast Asia Central Nervous System Biomarkers Market Size Forecast (2019-2025)(Million USD)
  • Figure India Central Nervous System Biomarkers Market Size Forecast (2019-2025)(Million USD)
  • Figure Central & South America Central Nervous System Biomarkers Market Size Forecast (2019-2025)(Million USD)
  • Table Global Central Nervous System Biomarkers Market Size by Product (2019-2025) (Million US$)
  • Figure Global Central Nervous System Biomarkers Market Size by Product (2019-2025)
  • Figure Global Central Nervous System Biomarkers Market Size by Product in 2025
  • Table Global Central Nervous System Biomarkers Market Size by Application (2019-2025) (Million US$)
  • Figure Global Central Nervous System Biomarkers Market Size by Application (2019-2025)
  • Figure Global Central Nervous System Biomarkers Market Size by Application in 2025
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources
目次

With extensive ongoing development in personalized medicines and the application of biomarkers in diagnosis, the complexity of the central nervous system paves way for the development of biomarkers to enhance early diagnosis of neurological disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and other neurological conditions.

In 2018, the global Central Nervous System Biomarkers market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Central Nervous System Biomarkers status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Central Nervous System Biomarkers development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

  • Merck
  • Takeda Pharmaceutical
  • Thermo Fisher Scientific
  • Avacta Group
  • Diagenic Asa
  • Banyan Biomarkers
  • Eli Lilly
  • Pfizer
  • Alseres Pharmaceuticals
  • Acumen pharmaceuticals
  • EKF Diagnostics
  • Abiant
  • Myriad RBM
  • Aposense

Market segment by Type, the product can be split into

  • Safety Biomarker
  • Efficacy Biomarker
  • Validation Biomarker
  • Other

Market segment by Application, split into

  • Hospitals
  • Clinics
  • Others

Market segment by Regions/Countries, this report covers

  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America

The study objectives of this report are:

  • To analyze global Central Nervous System Biomarkers status, future forecast, growth opportunity, key market and key players.
  • To present the Central Nervous System Biomarkers development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Central Nervous System Biomarkers are as follows:

  • History Year: 2014-2018
  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Central Nervous System Biomarkers Market Size Growth Rate by Type (2014-2025)
    • 1.4.2 Safety Biomarker
    • 1.4.3 Efficacy Biomarker
    • 1.4.4 Validation Biomarker
    • 1.4.5 Other
  • 1.5 Market by Application
    • 1.5.1 Global Central Nervous System Biomarkers Market Share by Application (2019-2025)
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
    • 1.5.4 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Central Nervous System Biomarkers Market Size
  • 2.2 Central Nervous System Biomarkers Growth Trends by Regions
    • 2.2.1 Central Nervous System Biomarkers Market Size by Regions (2019-2025)
    • 2.2.2 Central Nervous System Biomarkers Market Share by Regions (2014-2019)
  • 2.3 Industry Trends
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter's Five Forces Analysis

3 Market Share by Key Players

  • 3.1 Central Nervous System Biomarkers Market Size by by Players
    • 3.1.1 Global Central Nervous System Biomarkers Revenue by by Players (2014-2019)
    • 3.1.2 Global Central Nervous System Biomarkers Revenue Market Share by by Players (2014-2019)
    • 3.1.3 Global Central Nervous System Biomarkers Market Concentration Ratio (CR5 and HHI)
  • 3.2 Central Nervous System Biomarkers Key Players Head office and Area Served
  • 3.3 Key Players Central Nervous System Biomarkers Product/Solution/Service
  • 3.4 Date of Enter into Central Nervous System Biomarkers Market
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

  • 4.1 Global Central Nervous System Biomarkers Market Size by Type (2014-2019)
  • 4.2 Global Central Nervous System Biomarkers Market Size by Application (2014-2019)

5 North America

  • 5.1 North America Central Nervous System Biomarkers Market Size (2014-2019)
  • 5.2 Central Nervous System Biomarkers Key Players in North America
  • 5.3 North America Central Nervous System Biomarkers Market Size by Type
  • 5.4 North America Central Nervous System Biomarkers Market Size by Application

6 Europe

  • 6.1 Europe Central Nervous System Biomarkers Market Size (2014-2019)
  • 6.2 Central Nervous System Biomarkers Key Players in Europe
  • 6.3 Europe Central Nervous System Biomarkers Market Size by Type
  • 6.4 Europe Central Nervous System Biomarkers Market Size by Application

7 China

  • 7.1 China Central Nervous System Biomarkers Market Size (2014-2019)
  • 7.2 Central Nervous System Biomarkers Key Players in China
  • 7.3 China Central Nervous System Biomarkers Market Size by Type
  • 7.4 China Central Nervous System Biomarkers Market Size by Application

8 Japan

  • 8.1 Japan Central Nervous System Biomarkers Market Size (2014-2019)
  • 8.2 Central Nervous System Biomarkers Key Players in Japan
  • 8.3 Japan Central Nervous System Biomarkers Market Size by Type
  • 8.4 Japan Central Nervous System Biomarkers Market Size by Application

9 Southeast Asia

  • 9.1 Southeast Asia Central Nervous System Biomarkers Market Size (2014-2019)
  • 9.2 Central Nervous System Biomarkers Key Players in Southeast Asia
  • 9.3 Southeast Asia Central Nervous System Biomarkers Market Size by Type
  • 9.4 Southeast Asia Central Nervous System Biomarkers Market Size by Application

10 India

  • 10.1 India Central Nervous System Biomarkers Market Size (2014-2019)
  • 10.2 Central Nervous System Biomarkers Key Players in India
  • 10.3 India Central Nervous System Biomarkers Market Size by Type
  • 10.4 India Central Nervous System Biomarkers Market Size by Application

11 Central & South America

  • 11.1 Central & South America Central Nervous System Biomarkers Market Size (2014-2019)
  • 11.2 Central Nervous System Biomarkers Key Players in Central & South America
  • 11.3 Central & South America Central Nervous System Biomarkers Market Size by Type
  • 11.4 Central & South America Central Nervous System Biomarkers Market Size by Application

12 International Players Profiles

  • 12.1 Merck
    • 12.1.1 Merck Company Details
    • 12.1.2 Company Description and Business Overview
    • 12.1.3 Central Nervous System Biomarkers Introduction
    • 12.1.4 Merck Revenue in Central Nervous System Biomarkers Business (2014-2019))
    • 12.1.5 Merck Recent Development
  • 12.2 Takeda Pharmaceutical
    • 12.2.1 Takeda Pharmaceutical Company Details
    • 12.2.2 Company Description and Business Overview
    • 12.2.3 Central Nervous System Biomarkers Introduction
    • 12.2.4 Takeda Pharmaceutical Revenue in Central Nervous System Biomarkers Business (2014-2019)
    • 12.2.5 Takeda Pharmaceutical Recent Development
  • 12.3 Thermo Fisher Scientific
    • 12.3.1 Thermo Fisher Scientific Company Details
    • 12.3.2 Company Description and Business Overview
    • 12.3.3 Central Nervous System Biomarkers Introduction
    • 12.3.4 Thermo Fisher Scientific Revenue in Central Nervous System Biomarkers Business (2014-2019)
    • 12.3.5 Thermo Fisher Scientific Recent Development
  • 12.4 Avacta Group
    • 12.4.1 Avacta Group Company Details
    • 12.4.2 Company Description and Business Overview
    • 12.4.3 Central Nervous System Biomarkers Introduction
    • 12.4.4 Avacta Group Revenue in Central Nervous System Biomarkers Business (2014-2019)
    • 12.4.5 Avacta Group Recent Development
  • 12.5 Diagenic Asa
    • 12.5.1 Diagenic Asa Company Details
    • 12.5.2 Company Description and Business Overview
    • 12.5.3 Central Nervous System Biomarkers Introduction
    • 12.5.4 Diagenic Asa Revenue in Central Nervous System Biomarkers Business (2014-2019)
    • 12.5.5 Diagenic Asa Recent Development
  • 12.6 Banyan Biomarkers
    • 12.6.1 Banyan Biomarkers Company Details
    • 12.6.2 Company Description and Business Overview
    • 12.6.3 Central Nervous System Biomarkers Introduction
    • 12.6.4 Banyan Biomarkers Revenue in Central Nervous System Biomarkers Business (2014-2019)
    • 12.6.5 Banyan Biomarkers Recent Development
  • 12.7 Eli Lilly
    • 12.7.1 Eli Lilly Company Details
    • 12.7.2 Company Description and Business Overview
    • 12.7.3 Central Nervous System Biomarkers Introduction
    • 12.7.4 Eli Lilly Revenue in Central Nervous System Biomarkers Business (2014-2019)
    • 12.7.5 Eli Lilly Recent Development
  • 12.8 Pfizer
    • 12.8.1 Pfizer Company Details
    • 12.8.2 Company Description and Business Overview
    • 12.8.3 Central Nervous System Biomarkers Introduction
    • 12.8.4 Pfizer Revenue in Central Nervous System Biomarkers Business (2014-2019)
    • 12.8.5 Pfizer Recent Development
  • 12.9 Alseres Pharmaceuticals
    • 12.9.1 Alseres Pharmaceuticals Company Details
    • 12.9.2 Company Description and Business Overview
    • 12.9.3 Central Nervous System Biomarkers Introduction
    • 12.9.4 Alseres Pharmaceuticals Revenue in Central Nervous System Biomarkers Business (2014-2019)
    • 12.9.5 Alseres Pharmaceuticals Recent Development
  • 12.10 Acumen pharmaceuticals
    • 12.10.1 Acumen pharmaceuticals Company Details
    • 12.10.2 Company Description and Business Overview
    • 12.10.3 Central Nervous System Biomarkers Introduction
    • 12.10.4 Acumen pharmaceuticals Revenue in Central Nervous System Biomarkers Business (2014-2019)
    • 12.10.5 Acumen pharmaceuticals Recent Development
  • 12.11 EKF Diagnostics
  • 12.12 Abiant
  • 12.13 Myriad RBM
  • 12.14 Aposense

13 Market Forecast 2019-2025

  • 13.1 Market Size Forecast by Product (2019-2025)
  • 13.2 Market Size Forecast by Application (2019-2025)
  • 13.3 Market Size Forecast by Regions
  • 13.4 North America
  • 13.5 Europe
  • 13.6 China
  • 13.7 Japan
  • 13.8 Southeast Asia
  • 13.9 India
  • 13.10 Central & South America

14 Analyst's Viewpoints/Conclusions

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
      • 15.1.1.1 Research Programs/Design
      • 15.1.1.2 Market Size Estimation
      • 15.1.1.3 Market Breakdown and Data Triangulation
    • 15.1.2 Data Source
      • 15.1.2.1 Secondary Sources
      • 15.1.2.2 Primary Sources
  • 15.2 Disclaimer
  • 15.3 Author Details